These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1084 related items for PubMed ID: 9420337
1. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A. N Engl J Med; 1998 Jan 08; 338(2):73-8. PubMed ID: 9420337 [Abstract] [Full Text] [Related]
2. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A. N Engl J Med; 1989 Nov 16; 321(20):1349-52. PubMed ID: 2811943 [Abstract] [Full Text] [Related]
3. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. Tallstedt L, Lundell G, Tørring O, Wallin G, Ljunggren JG, Blomgren H, Taube A. N Engl J Med; 1992 Jun 25; 326(26):1733-8. PubMed ID: 1489388 [Abstract] [Full Text] [Related]
5. Graves' ophthalmopathy and 131I therapy. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A. Q J Nucl Med; 1999 Dec 08; 43(4):307-12. PubMed ID: 10731781 [Abstract] [Full Text] [Related]
6. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine. Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G. Clin Invest Med; 1999 Aug 08; 22(4):132-9. PubMed ID: 10497711 [Abstract] [Full Text] [Related]
7. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA, Daykin J, Holder R, Sheppard MC. QJM; 1995 Mar 08; 88(3):175-80. PubMed ID: 7767667 [Abstract] [Full Text] [Related]
8. Radioiodine therapy versus antithyroid medications for Graves' disease. Ma C, Xie J, Wang H, Li J, Chen S. Cochrane Database Syst Rev; 2016 Feb 18; 2(2):CD010094. PubMed ID: 26891370 [Abstract] [Full Text] [Related]
9. Treatment of Graves' hyperthyroidism--prognostic factors for outcome. Alfadda A, Malabu UH, El-Desouki MI, Al-Rubeaan KA, Al-Ruhaily AD, Fouda MA, Al-Maatouq MA, Sulimani RA. Saudi Med J; 2007 Feb 18; 28(2):225-30. PubMed ID: 17268701 [Abstract] [Full Text] [Related]
10. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A. Thyroid; 1992 Feb 18; 2(2):171-8. PubMed ID: 1525588 [Abstract] [Full Text] [Related]
11. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T. N Engl J Med; 1991 Apr 04; 324(14):947-53. PubMed ID: 1900575 [Abstract] [Full Text] [Related]
12. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication? Kobe C, Weber I, Eschner W, Sudbrock F, Schmidt M, Dietlein M, Schicha H. Nuklearmedizin; 2008 Apr 04; 47(4):153-6. PubMed ID: 18690374 [Abstract] [Full Text] [Related]
13. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC, Zanin DE, Zweers EJ. Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370 [Abstract] [Full Text] [Related]
14. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL. Radiol Med; 2000 Dec 28; 100(6):480-3. PubMed ID: 11307510 [Abstract] [Full Text] [Related]
15. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. Andrade VA, Gross JL, Maia AL. J Clin Endocrinol Metab; 2001 Aug 28; 86(8):3488-93. PubMed ID: 11502768 [Abstract] [Full Text] [Related]
16. Radioactive iodine therapy in Graves' hyperthyroidism. Sankar R, Sripathy G. Natl Med J India; 2000 Aug 28; 13(5):246-51. PubMed ID: 11190053 [Abstract] [Full Text] [Related]
17. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies. Chen DY, Schneider PF, Zhang XS, Luo XY, He ZM, Chen TH. Exp Clin Endocrinol Diabetes; 2014 Jan 28; 122(1):1-6. PubMed ID: 24203649 [Abstract] [Full Text] [Related]
18. Remission of Graves' hyperthyroidism treated with methimazole. Bolaños F, González-Ortiz M, Durón H, Sánchez C. Rev Invest Clin; 2002 Jan 28; 54(4):307-10. PubMed ID: 12415954 [Abstract] [Full Text] [Related]
19. Long-term follow-up study of radioiodine treatment of hyperthyroidism. Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J. Clin Endocrinol (Oxf); 2004 Nov 28; 61(5):641-8. PubMed ID: 15521969 [Abstract] [Full Text] [Related]
20. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A. J Clin Endocrinol Metab; 2001 Aug 28; 86(8):3562-7. PubMed ID: 11502779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]